QA: Pear Therapeutics Inc. in us_health_services/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001835567_2022_Pear_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001835567, Pear Therapeutics Inc.

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 5,253,000
2 AssetsCurrent 185,241,000
3 PropertyPlantAndEquipment 6,255,000
4 remainder_Assets 411,000
5 LongTermLiabilities 1,994,000
6 LiabilitiesCurrent 47,166,000
7 remainder_Liabilities 57,566,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 5,233,000
10 GeneralAndAdministrativeExpense 67,619,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 37,041,000
16 remainder_Expenses 0
17 remainder_Revenues 4,208,000
18 remainder_NetIncome 40,543,000
19 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Assets 197,160,000
1 Liabilities 106,726,000
2 Expenses 109,893,000
3 Revenues 4,208,000
4 StockholdersEquity 90,434,000
5 NetIncome -65,142,000
6 ComprehensiveNetIncome -65,143,000
7 BaseVar 254,781,925
8 EconomicCapitalRatio 0.436

Edgar->Model Mapping

Feature Distribution

Change over Time